The NHS in England will offer an artificial pancreas to help manage type 1 diabetes. diabetes
more than 100,000 people with type 1 diabetes England An artificial pancreas is to be offered, which experts believe could become the “holy grail” for managing the disease.
The groundbreaking device uses algorithms to determine the amount of insulin that needs to be administered and takes readings to keep blood sugar levels stable.
a world-first trial found on the NHS that it was more effective at managing diabetes than current devices and required much less input from patients. The device is now set to be rolled out across the NHS in England after receiving approval from the National Institute for Health and Care Excellence (Nice).
Mark Chapman, interim director of medical technology at Nice, said: “Some people with type 1 diabetes struggle to manage their condition, even when they are doing everything their diabetes team has told them to, except treatment. , this technology is the best intervention to help them control their diabetes.”
In draft guidance published Tuesday, an independent Nice committee recommended its use for managing blood sugar levels in people struggling to manage type 1 diabetes. This technology allows the patient to go about their daily life without being monitored to see if their blood sugar levels are too high or too low.
Women who are pregnant are also eligible, as it is difficult to manage blood sugar levels during this time. In total, the technology will be offered to around 105,000 people in England.
Managing type 1 diabetes can be challenging, especially in young children, due to variations in required insulin levels and uncertainty about how much patients eat and exercise. Children are especially at risk of dangerously low (hypoglycaemia) and high (hyperglycaemia) blood sugar levels, which can damage the body or even cause death.
The artificial pancreas is worn next to the body. It continuously monitors blood sugar levels and automatically adjusts insulin delivered through a pump.
It also eliminates the need for finger-prick tests to check blood sugar levels to prevent hypoglycaemic and hyperglycaemic attacks.
DRAFT NICE RECOMMENDATIONS ARE REQUIRED NHS England will agree a cost-effective price for the device on behalf of the relevant health bodies. Currently, the average annual cost for the technology is £5,744, which is high considering the cost-effective use of NHS resources.
Although the majority of the NHS’s estimated £10bn annual spending on diabetes goes to type 2 diabetes, it is hoped the devices will help cut costs by ensuring less need for intervention for type 1 cases.
“Our committee has reviewed real-world data generated by the NHS and evidence generated from randomized controlled trials that show there are clear benefits to recommending the use of the technology,” Chapman said. “We look forward to working with NHS England and industry to ensure that an appropriate cost-effective price for taxpayers is reached.”
Professor Partha Kar, national expert advisor on diabetes at NHS England, said: “This technology has proven to be the best control for managing type 1 diabetes and things like amputations, blindness and kidney problems should probably be made a thing of the past.”
Kar, who previously described the device as “not too far from the holy grail of a fully automated system”, said: “We’ve seen great results from the real-world tests that have taken place. This technology is ready to use.” Provides quality of life to residents.
Six-year-old Charlotte Abbott-Pearce was one of the first people to benefit from an artificial pancreas.
“Before the hybrid closed-loop system was fitted, my husband and I checked Charlotte’s blood sugar every two hours every night and gave insulin most of the times, sometimes with a finger prick or a blood sugar rapid test. dealt with ketones as he grew,” his mother, Ang Abbott-Pierce, told the Guardian last year, She said that the new system was “God’s gift to us as we were at our wit’s end with anxiety, not able to hold the heights before they became dangerous”.
#NHS #England #offer #artificial #pancreas #manage #type #diabetes #diabetes